Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4480
NNVC
NanoViricides, Inc. Common Stock
1.24 USD-3.88%-5.34%-20.00%+22.76%26.84 M USD
4484
LTRN
Lantern Pharma Inc. - Common Stock
2.07 USD-4.17%-8.81%-17.53%-50.60%26.46 M USD
4501
EVAX
Evaxion A/S - American Depositary Share
3.01 USD-4.44%-9.34%+7.50%-9.34%25.10 M USD
4512
TVRD
Tvardi Therapeutics, Inc. - Common Stock
1.82 USD+0.55%-2.67%-14.15%-49.44%24.28 M USD

Frequently asked questions about Atossa Therapeutics, Inc. Common Stock

What is the Atossa Therapeutics, Inc. Common Stock stock price today?

The current price of Atossa Therapeutics, Inc. Common Stock (ATOS) is 2.58. Over the past 24 hours, the stock has changed by -2.27%. Follow the ATOS chart for real-time price dynamics.

What is the stock ticker of Atossa Therapeutics, Inc. Common Stock?

Atossa Therapeutics, Inc. Common Stock trades under the ticker ATOS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Atossa Therapeutics, Inc. Common Stock stock going up?

ATOS has changed by +0.78% over the last week, +12.66% over the last month, and +239.47% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Atossa Therapeutics, Inc. Common Stock?

Atossa Therapeutics, Inc. Common Stock currently has a market capitalization of 25.75 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Atossa Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Atossa Therapeutics, Inc. Common Stock reported earnings of -0.95 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Atossa Therapeutics, Inc. Common Stock net income for the last quarter?

Atossa Therapeutics, Inc. Common Stock reported net income of -8.49 M for the last quarter. The previous quarter showed -9.59 M, which means net income changed by +11.45%.

How many employees does Atossa Therapeutics, Inc. Common Stock have?

As of the latest available data, Atossa Therapeutics, Inc. Common Stock has 14 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Atossa Therapeutics, Inc. Common Stock stock?

You can buy Atossa Therapeutics, Inc. Common Stock (ATOS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Atossa Therapeutics, Inc. Common Stock stock?

Investing in Atossa Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ATOS chart and related analysis on metatrader.com as part of your research.

News